Earkart Ltd (544549) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 544549 | NSE: | Medical Equipment/Supplies/Accessories | Small Cap

Earkart Share Price

180 0.00 0.00%
as on 04-Dec'25 16:59

Earkart Ltd (544549) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 544549 | NSE: | Medical Equipment/Supplies/Accessories | Small Cap

DeciZen - make an informed investing decision on Earkart

Based on:

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Earkart stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
37.28
Market Cap:
247.6 Cr.
52-wk low:
135.5
52-wk high:
266

Is Earkart Ltd an attractive stock to invest in?

1. Is Earkart Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Earkart Ltd is a below average quality company.

2. Is Earkart Ltd undervalued or overvalued?

The key valuation ratios of Earkart Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Earkart Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Earkart Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Earkart:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Earkart Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 2.3%24%29.1%44.4%-
Value Creation
Index
-0.80.71.12.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 5.728.931.843.143
Sales YoY Gr.-408.3%9.8%35.8%-
Adj EPS 0.11.73.96.34.8
YoY Gr.-1445.5%129.4%62.3%-
BVPS (₹) 6.38.717.218.946.9
Adj Net
Profit
0.11.32.96.67
Cash Flow from Ops. -2.8-0.3-10.7-
Debt/CF from Ops. -0.1-4.1-47-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA96.4%35.8%
Adj EPS NANA286.1%62.3%
BVPSNANA44.2%9.5%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
1.822.63040.214.7
Op. Profit
Mgn %
2.45.711.322.3NAN
Net Profit
Mgn %
1.54.49.315.315.4
Debt to
Equity
0.10.20.30.3-
Working Cap
Days
01131741880
Cash Conv.
Cycle
036911370

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 96.41%

Net Profit is growing at healthy rate in last 3 years 286.07%

Return on Equity has declined versus last 3 years average to 14.70%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Earkart Ltd.

Standalone Consolidated
TTM EPS (₹) 4.8 -
TTM Sales (₹ Cr.) 43.1 -
BVPS (₹.) 46.9 -
Reserves (₹ Cr.) 51 -
P/BV 3.84 -
PE 37.28 -
From the Market
52 Week Low / High (₹) 135.50 / 265.95
All Time Low / High (₹) 135.50 / 265.95
Market Cap (₹ Cr.) 248
Equity (₹ Cr.) 13.8
Face Value (₹) 10
Industry PE 53.3

Management X-Ray of Earkart:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Earkart - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Earkart

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales6293243
Operating Expenses 6272834
Manufacturing Costs0121
Material Costs2202025
Employee Cost 1334
Other Costs 2434
Operating Profit 02410
Operating Profit Margin (%) 2.4%5.6%11.3%22.3%
Other Income 0000
Interest 0000
Depreciation 0000
Exceptional Items 0000
Profit Before Tax 0139
Tax 0002
Profit After Tax 0137
PAT Margin (%) 1.9%4.5%9.6%15.4%
Adjusted EPS (₹)0.11.74.16.4
Dividend Payout Ratio (%)0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 571320
Share Capital 00010
Reserves 56139
Minority Interest0000
Debt0145
Long Term Debt0000
Short Term Debt0145
Trade Payables1613
Others Liabilities 0112
Total Liabilities 6151930

Fixed Assets

Gross Block0012
Accumulated Depreciation0001
Net Fixed Assets 0011
CWIP 0000
Investments 1001
Inventories1567
Trade Receivables25619
Cash Equivalents 0110
Others Assets 2443
Total Assets 6151930

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -3-0-11
PBT 0139
Adjustment 0011
Changes in Working Capital -3-2-5-7
Tax Paid -0-0-0-2
Cash Flow From Investing Activity -20-1-1
Capex -0-0-1-1
Net Investments -11-0-1
Others -0-1-0-0
Cash Flow From Financing Activity 503-0
Net Proceeds from Shares 5030
Net Proceeds from Borrowing 0000
Interest Paid 0-0-0-0
Dividend Paid 0000
Others 0-000
Net Cash Flow 011-1

Finance Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)2.2223.2731.3140.63
ROCE (%)2.3424.0229.0544.39
Asset Turnover Ratio0.962.81.871.74
PAT to CFO Conversion(x)N/A-0-0.330.14
Working Capital Days
Receivable Days1044063106
Inventory Days48396754
Payable Days93586330

Earkart Ltd Stock News

Earkart Ltd FAQs

The current trading price of Earkart on 04-Dec-2025 16:59 is ₹180.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Dec-2025 the market cap of Earkart stood at ₹247.6.
The latest P/E ratio of Earkart as of 03-Dec-2025 is 37.28.
The latest P/B ratio of Earkart as of 03-Dec-2025 is 3.84.
The 52-week high of Earkart is ₹265.9 and the 52-week low is ₹135.5.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Earkart is ₹43.11 ( Cr.) .

About Earkart Ltd

Earkart Limited was incorporated as ‘Earkart Private Limited’ a Private Limited Company in Noida, Uttar Pradesh on April 14, 2021. Thereafter, name of the company was changed from ‘Earkart Private Limited’ to ‘Earkart Limited’, consequent to conversion of the company from Private to Public Company, pursuant to a special resolution passed by the shareholders of the company on November 27, 2024.

The company manufactures and distributes modern hearing aids and related accessories at affordable prices across India. Along with their own manufactured hearing aid, it also trades in hearing aid, parts and accessories of other brands manufactured in India and abroad. In addition, it offers other products like adjustable foldable walkers and MultiSensory Integrated Educational Development (MSIED) and Teaching Learning Material (TLM) kits to support mobility and daily needs of physically challenged. It has developed a smart and easy-to-use remote audiometry machine that allows people to get tested and fitted for hearing aids from anywhere in the world.

It offers hearing solutions through its network of partners and clinics across India, which sell both domestic and global hearing aid brands. The company focuses on Tier 2 and Tier 3 cities, where it aims to bridge the accessibility gap using innovative delivery models like branded kiosks and dedicated telehealth services. The company is a trusted supplier on the Government e-Marketplace (GeM) and provides hearing aids to Artificial Limbs Manufacturing Corporation of India (ALIMCO). ALIMCO is 100% government owned enterprise functioning under the Administrative Control of Ministry of Social Justice & Empowerment, Department of Empowerment of Persons with Disabilities.

Business area of the company 

The company assembles, manufactures, sells, trades, provides after sales services (including user training) and undertakes research and development of affordable hearing aids, MSIED Kits, TLM Kits & other rehabilitation products, including their components, accessories and parts thereof. The company focuses on Tier 2 and Tier 3 cities, where it aims to bridge the accessibility gap using innovative delivery models like branded kiosks and dedicated telehealth services.

Products and Services of the company

Products 

  • Hearing Aids: The company manufactures three types of hearing aids, marketed under the brand names EQFYTM, Fame, and Radius. EQFYTM offers a single product, the Fame series includes four different product variation, and the Radius brand features eleven different product variations.
  • Hearing Aids Accessories: Hearing Aid Accessories are additional items designed to support the use, care, and performance of hearing aids. They include products like ear buds for a better fit, batteries for power, cleaning tools like brushes, wax guards to protect the device, and battery testers to ensure proper function. 
  • MSIED Kit: It has been designed for educational purpose for Mentally Challenged.
  • TLM Kit: Teaching Learning Material (TLM) Kit consists of various products/materials used for education purpose and designed for 0-3 year age group, 3-6 year age group and 6 years above till 18 years.
  • ADJUSTABLE WALKER - FOLDABLE: Adjustable foldable walker is perfectly combined with its lightweight frame ensuring easy storage, portability and durability.

Services

  • Support services - Consultancy charges
  • Support services - Conversion Charge
  • Franchisee Fees
  • Audiometry Charge

History and milestones

  • 2021: Launch of earKART CRM and dealer App.
  • 2022: Bureau of Indian Standards (BIS) license received.
  • 2022: First government order received for 10,000 Hearing Aids units.
  • 2023: Granted ISO 13485:2016.
  • 2023: Licence to Manufacture for Sale or for Distribution of Class A or Class B medical device.
  • 2024: Launch of ENT (Shop in Shop Model).
  • 2024: Launch of remote video Audiometry Device OMNI.
  • 2024: Conversion into a Public Limited Company.
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×